National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$85.50
add to cart

Rights & Permissions

topleft topright

The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions: Workshop Summary (2010)
Board on Global Health (BGH)

Citation Manager

. "Appendix D Glossary." The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions: Workshop Summary. Washington, DC: The National Academies Press, 2010.

Please select a format:

BibTeX EndNote RefMan


Page
390
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


The Domestic and International Impacts of the 2009-H1N1 Influenza a Pandemic: Global Challenges, Global Solutions - Workshop Summary

Cross-reactive cell-mediated immunity: An immune response that does not involve antibodies but rather involves the activation of macrophages, natural killer cells (NK), antigen-specific cytotoxic T-lymphocytes, and the release of various cytokines in response to an antigen (http://encyclopedia.thefreedictionary.com/cell-mediated+immunity, accessed November 5, 2009).

Dilution: A method of obtaining a pure culture of bacteria or virus by subculturing from the highest dilution in which the organism is demonstrably present (http://medical-dictionary.thefreedictionary.com/limit+dilution, accessed November 5, 2009).

Distributive justice: Benefits and burdens imposed on the population when the emergency response measures and mitigations are shared equitably and fairly. Endemic: The constant presence of a disease or infectious agent within a given geographic area; it may also refer to the usual prevalence of a given disease within such area.

Enzootic: A disease (can be either low or high morbidity) that is endemic in an animal community.

Epidemic: The occurrence in a community or region of cases of an illness (or outbreak) with a frequency clearly in excess of normal expectancy. Epidemiology: The branch of science that deals with the incidence, distribution, and control of disease in a population; the sum of the factors controlling the presence or abundance of a disease or pathogen.

Epitopes: The surface portion of an antigen capable of eliciting an immune response and of combining with the antibody produced to counter that response (http://medical-dictionary.thefreedictionary.com/epitopes, accessed November 5, 2009).

Epi-X: Centers for Disease Control and Prevention’s Web-based communications solution for public health professionals. Through Epi-X, CDC officials, state and local health departments, poison control centers, and other public health professionals can access and share preliminary health surveillance information— quickly and securely. Users can also be actively notified of breaking health events as they occur. For more information, see http://www.cdc.gov/epix/ (accessed November 5, 2009).

Founder effect: Changes in gene frequencies that usually accompany starting a new population from a small number of individuals. The newly founded population is likely to have quite different gene frequencies than the source population because

Page
390
Front Matter (R1-R22)
Workshop Overview (1-94)
Appendix A1 Technical Report for State and Local Public Health Officials and School Administrators on CDC Guidance for School (K-12) Responses to Influenza during the 2009-2010 School Year (95-110)
A2 Predicting Emerging Diseases in the Twenty-first Century: The Case of Zoonotic Influenza (111-119)
A3 The Spring 2009 Influenza A H1N1 Outbreak: A Local Public Health Perspective (120-136)
A4 I nternational Law and Equitable Access to Vaccines and Antivirals in the Context of 2009-H1N1 Influenza (137-154)
A5 In Vitro and In Vivo Characterization of New Swine-Origin H1N1 Influenza Viruses (155-190)
A6 Estimation of the Reproductive Number and the Serial Interval in Early Phase of the 2009 Influenza A⁄H1N1 Pandemic in the USA (191-207)
A7 The Severity of Pandemic H1N1 Influenza in the United States, from April to July 2009: A Bayesian Analysis (208-247)
A8 Hard Choices in Difficult Situations: Ethical Issues in Public Health Emergencies (248-268)
A9 Rumors of Pandemic: Monitoring Emerging Disease Outbreaks on the Internet (269-282)
A10 Preliminary Observation of the Epidemiology of Seasonal and Pandemic Influenza A (H1N1) in South Africa, 2009 (283-296)
A11 Reflections on the 1976 Swine Flu Vaccination Program (297-305)
A12 Southern Hemisphere, Northern Hemisphere: A Global Influenza World (306-326)
A13 Influenza (H1N1) Pandemic 2009 (327-341)
A14 Origins and Evolutionary Genomics of the 2009 Swine-Origin H1N1 Influenza A Epidemic (342-380)
Appendix B Agenda (381-385)
Appendix C Acronyms (386-388)
Appendix D Glossary (389-396)
Appendix E Forum Member Biographies (397-418)